Stockscreener 앱 받기
11.36
2.11%
-0.245
전일 마감가:
$11.60
열려 있는:
$11.6
하루 거래량:
2.78M
Relative Volume:
0.56
시가총액:
$1.22B
수익:
$45.97M
순이익/손실:
$-508.80M
주가수익비율:
-2.0721
EPS:
-5.48
순현금흐름:
$-382.65M
1주 성능:
+7.94%
1개월 성능:
-9.16%
6개월 성능:
+4.56%
1년 성능:
-50.63%
1일 변동 폭
$11.16
$11.65
1주일 범위
$10.92
$11.95
52주 변동 폭
$5.90
$23.76
Intellia Therapeutics Inc Stock (NTLA) Company Profile
명칭
Intellia Therapeutics Inc
전화
857-285-6200
주소
40 ERIE STREET, CAMBRIDGE, MA
NTLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTLA
Intellia Therapeutics Inc
|
11.36 | 1.25B | 45.97M | -508.80M | -382.65M | -5.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Intellia Therapeutics Inc Stock (NTLA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-05 | 개시 | H.C. Wainwright | Buy |
| 2025-02-28 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-23 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-02-15 | 개시 | Wolfe Research | Peer Perform |
| 2023-04-13 | 개시 | Canaccord Genuity | Buy |
| 2023-03-21 | 개시 | Bernstein | Outperform |
| 2023-03-14 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-02-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-24 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-09-01 | 개시 | Citigroup | Sell |
| 2022-06-17 | 개시 | BMO Capital Markets | Market Perform |
| 2022-06-16 | 개시 | BofA Securities | Buy |
| 2022-04-28 | 개시 | Credit Suisse | Outperform |
| 2022-02-18 | 개시 | William Blair | Outperform |
| 2022-02-07 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-31 | 개시 | Cowen | Outperform |
| 2022-01-07 | 개시 | Piper Sandler | Overweight |
| 2021-10-05 | 개시 | Guggenheim | Buy |
| 2021-09-24 | 개시 | Stifel | Buy |
| 2021-06-28 | 재확인 | H.C. Wainwright | Buy |
| 2021-06-11 | 개시 | H.C. Wainwright | Buy |
| 2021-05-07 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-05-04 | 개시 | RBC Capital Mkts | Outperform |
| 2021-03-04 | 개시 | JMP Securities | Mkt Outperform |
| 2020-12-22 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-27 | 개시 | Truist | Buy |
| 2020-10-14 | 개시 | Wells Fargo | Overweight |
| 2020-09-18 | 개시 | Goldman | Buy |
| 2020-02-28 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-11-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-07-09 | 개시 | Robert W. Baird | Outperform |
| 2019-06-10 | 개시 | ROTH Capital | Neutral |
| 2019-05-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
| 2018-11-02 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-10-29 | 개시 | Credit Suisse | Neutral |
| 2018-09-21 | 개시 | Raymond James | Mkt Perform |
| 2018-05-15 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2018-03-08 | 개시 | JMP Securities | Mkt Outperform |
| 2017-11-01 | 재확인 | Jefferies | Buy |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2017-03-28 | 개시 | Chardan Capital Markets | Buy |
| 2016-08-05 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Intellia Therapeutics Inc 주식(NTLA)의 최신 뉴스
Intellia Therapeutics Inc. stock chart pattern explainedJuly 2025 Review & Weekly High Potential Stock Alerts - Newser
Pattern recognition hints at Intellia Therapeutics Inc. upsideJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Multi asset correlation models including Intellia Therapeutics Inc.Oil Prices & Weekly Watchlist for Consistent Profits - Newser
Applying sector rotation models to Intellia Therapeutics Inc.2025 Big Picture & AI Powered Trade Plan Recommendations - Newser
Why Intellia Therapeutics Inc. is moving todayWeekly Risk Report & AI Forecast Swing Trade Picks - Newser
Is Intellia Therapeutics Inc. stock reversal real or fakeJuly 2025 PostEarnings & Verified Short-Term Plans - Newser
Intellia Therapeutics Inc. stock prediction for this week2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Is Intellia Therapeutics Inc. building a consolidation baseJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Chart based analysis of Intellia Therapeutics Inc. trendsJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
Intellia Therapeutics Inc. stock outlook for YEARJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Leading vs lagging indicators on Intellia Therapeutics Inc. performancePortfolio Growth Summary & Momentum Based Trading Signals - Newser
Detecting support and resistance levels for Intellia Therapeutics Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Is Intellia Therapeutics Inc. a candidate for recovery playDay Trade & Daily Profit Maximizing Tips - Newser
Will Intellia Therapeutics Inc. bounce back from current support2025 Dividend Review & Risk Controlled Daily Trade Plans - Newser
Is Intellia Therapeutics Inc. trending in predictive chart modelsOil Prices & Free Technical Confirmation Trade Alerts - Newser
Tools to assess Intellia Therapeutics Inc.’s risk profileJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-30 20:19:07 - Newser
What the charts say about Intellia Therapeutics Inc. todayRisk Management & Technical Pattern Alert System - Newser
Cathie Wood Invests $4M in Intellia Therapeutics, Trims Stakes in Roku and DraftKings - AInvest
Using RSI to spot recovery in Intellia Therapeutics Inc.2025 Market Overview & Daily Oversold Bounce Ideas - Newser
Cathie Wood’s ARK Investment buys 133K shares of Intellia Therapeutics today - MSN
Cathie Wood’s ARK buys Intellia stock, trims DraftKings position By Investing.com - Investing.com South Africa
Identifying reversal signals in Intellia Therapeutics Inc.Portfolio Return Summary & Low Risk Investment Opportunities - Newser
Cathie Wood’s ARK buys Intellia stock, trims DraftKings position - Investing.com
Is Intellia Therapeutics Inc. stock poised for growthJuly 2025 Trends & Weekly Setup with ROI Potential - Newser
Intellia Therapeutics Inc. Stock Flags Risk Zone in Volatility Index getLinesFromResByArray error: size == 0 - thegnnews.com
Will Intellia Therapeutics Inc. benefit from macro trendsTrade Ideas & Stepwise Trade Signal Implementation - Newser
Combining price and volume data for Intellia Therapeutics Inc.Trade Volume Report & Daily Entry Point Alerts - Newser
Published on: 2025-08-29 13:52:57 - Newser
Visual analytics tools that track Intellia Therapeutics Inc. performanceTrade Analysis Summary & Safe Capital Growth Tips - Newser
Intellia Therapeutics Inc (NTLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):